Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Work In Process (2016 - 2025)

Fresenius Medical Care AG (FMS) has 16 years of Work In Process data on record, last reported at $171.0 million in Q4 2025.

  • For Q4 2025, Work In Process rose 28.92% year-over-year to $171.0 million; the TTM value through Dec 2025 reached $171.0 million, up 28.92%, while the annual FY2025 figure was $165.9 million, 23.54% up from the prior year.
  • Work In Process reached $171.0 million in Q4 2025 per FMS's latest filing, up from $132.6 million in the prior quarter.
  • Across five years, Work In Process topped out at $171.0 million in Q4 2025 and bottomed at $120.4 million in Q4 2021.
  • Average Work In Process over 4 years is $137.7 million, with a median of $129.8 million recorded in 2022.
  • Peak YoY movement for Work In Process: decreased 0.41% in 2021, then grew 28.92% in 2025.
  • A 4-year view of Work In Process shows it stood at $120.4 million in 2021, then rose by 5.4% to $126.9 million in 2022, then grew by 4.48% to $132.6 million in 2024, then increased by 28.92% to $171.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $171.0 million in Q4 2025, $132.6 million in Q4 2024, and $126.9 million in Q4 2022.